Table 3.
Hypoxia associated dysregulated microRNAs in breast cancer.
| MicroRNA | logFC | FDR* | regulated | HR | 95%CI lower | 95%CI upper | logrank P** |
|---|---|---|---|---|---|---|---|
| hsa-miR-210-3p | 2.357 | 1.51E-43 | Up-Regulated | 1.54 | 1.02 | 2.30 | 3.60E-02 |
| hsa-miR-224-5p | 1.729 | 2.52E-24 | Up-Regulated | 1.46 | 0.98 | 2.17 | 6.40E-02 |
| hsa-miR-934 | 1.614 | 1.44E-15 | Up-Regulated | 1.56 | 1.08 | 2.26 | 1.70E-02 |
| hsa-miR-105-5p | 1.613 | 5.53E-10 | Up-Regulated | 2.26 | 1.55 | 3.28 | 1.20E-05 |
| hsa-miR-135b-5p | 1.607 | 4.47E-21 | Up-Regulated | 1.29 | 0.92 | 1.81 | 1.50E-01 |
| hsa-miR-1825 | 1.483 | 6.51E-03 | Up-Regulated | 2.08 | 1.47 | 2.93 | 2.50E-05 |
| hsa-miR-767-5p | 1.460 | 1.50E-08 | Up-Regulated | 1.99 | 1.37 | 2.89 | 2.20E-04 |
| hsa-miR-9-5p | 1.436 | 1.79E-14 | Up-Regulated | 1.90 | 1.34 | 2.69 | 2.50E-04 |
| hsa-miR-577 | 1.389 | 3.37E-13 | Up-Regulated | 1.30 | 0.93 | 1.83 | 1.30E-01 |
| hsa-miR-452-5p | 1.257 | 1.18E-18 | Up-Regulated | 1.49 | 0.97 | 2.28 | 6.70E-02 |
| hsa-miR-187-3p | 1.214 | 9.63E-10 | Up-Regulated | 1.22 | 0.83 | 1.78 | 3.10E-01 |
| hsa-miR-18a-5p | 1.169 | 5.03E-28 | Up-Regulated | 1.27 | 0.90 | 1.79 | 1.70E-01 |
| hsa-miR-519a-5p | 1.115 | 3.94E-10 | Up-Regulated | 1.71 | 1.21 | 2.43 | 2.30E-03 |
| hsa-miR-452-3p | 1.090 | 1.19E-21 | Up-Regulated | 1.49 | 0.97 | 2.28 | 6.70E-02 |
| hsa-miR-455-3p | 1.081 | 2.87E-14 | Up-Regulated | 1.35 | 0.96 | 1.91 | 8.70E-02 |
| hsa-miR-375 | -1.364 | 4.45E-13 | Down-Regulated | 1.23 | 0.88 | 1.72 | 2.30E-01 |
| hsa-miR-190b | -1.426 | 1.29E-24 | Down-Regulated | 0.64 | 0.45 | 0.92 | 1.40E-02 |
*Limma R package; **Log-rank P test.